SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genta, Inc. (GNTA)
GNTA 2.300+0.4%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madharry who wrote (1728)7/31/2003 12:47:17 PM
From: Jim Oravetz   of 1870
 
Genta 2Q Loss 5c/Shr
DOW JONES NEWSWIRES

Genta Inc. - Berkeley Heights, N.J.
2nd Quar June 30:

                         2003                2002

Revenues              $1,320,000            $910,000

Net income            (3,418,000)        (17,069,000)

Avg shares            74,442,000          69,184,000

Shr earns

 Net income                 (.05)               (.25)

       6 months:

Revenues               2,629,000             915,000

Net income           (13,021,000)        (29,696,000)

Avg shares            74,338,000          67,862,000

Shr earns

 Net income                 (.18)               (.44)

Figures in parentheses are losses.

Genta Inc. (GNTA) is a biopharmaceutical company.

Company Web Site: genta.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News